CONGENITAL MUSCULAR DYSTROPHIES: EP.69 LAST STRONG: LAMA2 and SELENON to study trial readiness, outcome measures and natural history
| Autor: | Bouman, K., Groothuis, J., Doorduin, J., van Alfen, N., ten Cate, F. Udink, van den Heuvel, F., Nijveldt, R., van Tilburg, W., Buckens, S., Dittrich, A., Draaisma, J., Janssen, M., Kamsteeg, E., van Kleef, E., Smeitink, J., van Tienen, F., Smeets, H., van Engelen, B., Erasmus, C., Voermans, N. |
|---|---|
| Zdroj: | In Neuromuscular Disorders October 2021 31 Supplement 1:S70-S70 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect